A detailed history of Geneos Wealth Management Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 6,359 shares of DXCM stock, worth $495,620. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,359
Previous 5,938 7.09%
Holding current value
$495,620
Previous $673,000 36.7%
% of portfolio
0.02%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $26,944 - $48,861
421 Added 7.09%
6,359 $426,000
Q2 2024

Jul 23, 2024

SELL
$110.31 - $140.45 $9,707 - $12,359
-88 Reduced 1.46%
5,938 $673,000
Q1 2024

May 03, 2024

SELL
$114.22 - $140.1 $3,769 - $4,623
-33 Reduced 0.54%
6,026 $835,000
Q4 2023

Jan 26, 2024

SELL
$75.49 - $124.16 $27,100 - $44,573
-359 Reduced 5.59%
6,059 $751,000
Q3 2023

Oct 11, 2023

SELL
$86.06 - $137.93 $82,617 - $132,412
-960 Reduced 13.01%
6,418 $598,000
Q2 2023

Aug 08, 2023

BUY
$112.47 - $130.98 $138,675 - $161,498
1,233 Added 20.07%
7,378 $948,000
Q1 2023

Apr 25, 2023

SELL
$104.0 - $122.92 $138,736 - $163,975
-1,334 Reduced 17.84%
6,145 $713,000
Q4 2022

Jan 30, 2023

SELL
$84.98 - $122.67 $55,831 - $80,594
-657 Reduced 8.08%
7,479 $846,000
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $15,804 - $19,495
207 Added 2.61%
8,136 $655,000
Q2 2022

Jul 22, 2022

BUY
$67.99 - $132.89 $401,073 - $783,918
5,899 Added 290.59%
7,929 $590,000
Q1 2022

May 16, 2022

SELL
$94.08 - $130.2 $63,974 - $88,535
-680 Reduced 25.09%
2,030 $1.04 Million
Q4 2021

Feb 09, 2022

SELL
$129.87 - $162.82 $3,376 - $4,233
-26 Reduced 0.95%
2,710 $1.46 Million
Q3 2021

Nov 09, 2021

BUY
$106.71 - $143.18 $9,817 - $13,172
92 Added 3.48%
2,736 $1.5 Million
Q2 2021

Jul 08, 2021

BUY
$80.99 - $107.93 $114,033 - $151,965
1,408 Added 113.92%
2,644 $1.14 Million
Q1 2021

Jun 17, 2021

SELL
$84.79 - $104.74 $2,543 - $3,142
-30 Reduced 2.37%
1,236 $477,000
Q4 2020

May 19, 2021

BUY
$78.0 - $104.5 $8,580 - $11,495
110 Added 9.52%
1,266 $417,000
Q3 2020

Sep 07, 2021

SELL
$95.51 - $112.95 $6,208 - $7,341
-65 Reduced 5.32%
1,156 $465,000
Q2 2020

Sep 07, 2021

SELL
$62.68 - $105.34 $2,507 - $4,213
-40 Reduced 3.17%
1,221 $467,000
Q1 2020

Sep 07, 2021

BUY
$47.79 - $75.63 $4,301 - $6,806
90 Added 7.69%
1,261 $331,000
Q4 2019

Sep 07, 2021

SELL
$36.62 - $57.29 $3,661 - $5,729
-100 Reduced 7.87%
1,171 $255,000
Q1 2019

Sep 07, 2021

SELL
$28.07 - $38.18 $449 - $610
-16 Reduced 1.24%
1,271 $151,000
Q4 2018

Sep 07, 2021

BUY
$26.99 - $37.37 $2,699 - $3,736
100 Added 8.42%
1,287 $152,000
Q3 2018

Sep 07, 2021

SELL
$23.35 - $36.72 $3,782 - $5,948
-162 Reduced 12.01%
1,187 $169,000
Q2 2018

Sep 07, 2021

SELL
$17.54 - $25.22 $8,770 - $12,610
-500 Reduced 27.04%
1,349 $128,000
Q1 2018

Sep 07, 2021

BUY
$13.06 - $18.54 $3,591 - $5,098
275 Added 17.47%
1,849 $137,000
Q2 2017

Sep 07, 2021

SELL
N/A
-11 Reduced 0.69%
1,574 $115,000
Q1 2017

Sep 07, 2021

BUY
N/A
1,523 Added 2456.45%
1,585 $134,000
Q4 2016

Sep 07, 2021

BUY
N/A
24 Added 63.16%
62 $3,000
Q3 2016

Sep 07, 2021

BUY
N/A
38
38 $3,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.